These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 22186847)
1. Study of Octaplex dosing accuracy: an in vitro analysis. Patriquin CJ; Chin-Yee IH; Kovacs MJ; Lazo-Langner A; Keeney M; Hsia CC Thromb Haemost; 2012 Feb; 107(2):248-52. PubMed ID: 22186847 [TBL] [Abstract][Full Text] [Related]
2. Optimal dose of prothrombin complex concentrate for acute reversal of oral anticoagulation. Yasaka M; Sakata T; Naritomi H; Minematsu K Thromb Res; 2005; 115(6):455-9. PubMed ID: 15792675 [TBL] [Abstract][Full Text] [Related]
3. Prothrombin complex concentrates to reverse warfarin-induced coagulopathy in patients with intracranial bleeding. Cabral KP; Fraser GL; Duprey J; Gibbons BA; Hayes T; Florman JE; Seder DB Clin Neurol Neurosurg; 2013 Jun; 115(6):770-4. PubMed ID: 22835715 [TBL] [Abstract][Full Text] [Related]
4. Prothrombin complex concentrate (Octaplex) in patients requiring immediate reversal of oral anticoagulation. Riess HB; Meier-Hellmann A; Motsch J; Elias M; Kursten FW; Dempfle CE Thromb Res; 2007; 121(1):9-16. PubMed ID: 17407788 [TBL] [Abstract][Full Text] [Related]
5. A comparative study of prothrombin complex concentrates and fresh-frozen plasma for warfarin reversal under static and flow conditions. Ogawa S; Szlam F; Ohnishi T; Molinaro RJ; Hosokawa K; Tanaka KA Thromb Haemost; 2011 Dec; 106(6):1215-23. PubMed ID: 22071880 [TBL] [Abstract][Full Text] [Related]
6. Prothrombin complex concentrate versus standard therapies for INR reversal in trauma patients receiving warfarin. Chapman SA; Irwin ED; Beal AL; Kulinski NM; Hutson KE; Thorson MA Ann Pharmacother; 2011 Jul; 45(7-8):869-75. PubMed ID: 21775690 [TBL] [Abstract][Full Text] [Related]
7. Fixed versus variable dose of prothrombin complex concentrate for counteracting vitamin K antagonist therapy. Khorsand N; Veeger NJ; Muller M; Overdiek JW; Huisman W; van Hest RM; Meijer K Transfus Med; 2011 Apr; 21(2):116-23. PubMed ID: 21073580 [TBL] [Abstract][Full Text] [Related]
8. The effectiveness and safety of fixed low-dose prothrombin complex concentrates in patients requiring urgent reversal of warfarin. Varga C; Al-Touri S; Papadoukakis S; Caplan S; Kahn S; Blostein M Transfusion; 2013 Jul; 53(7):1451-8; quiz 1450. PubMed ID: 23067393 [TBL] [Abstract][Full Text] [Related]
9. Poor correlation of supratherapeutic international normalised ratio and vitamin K-dependent procoagulant factor levels during warfarin therapy. Sarode R; Rawal A; Lee R; Shen YM; Frenkel EP Br J Haematol; 2006 Mar; 132(5):604-7. PubMed ID: 16445834 [TBL] [Abstract][Full Text] [Related]
10. Prothrombin complex concentrates used alone in urgent reversal of warfarin anticoagulation. Tran H; Collecutt M; Whitehead S; Salem HH Intern Med J; 2011 Apr; 41(4):337-43. PubMed ID: 20403070 [TBL] [Abstract][Full Text] [Related]
11. Retrospective evaluation of a method to predict fresh-frozen plasma dosage in anticoagulated patients. Frazee LA; Bourguet CC; Gutierrez W; Elder-Arrington J; Elackattu AE; Haller NA Am J Ther; 2008; 15(2):111-8. PubMed ID: 18356630 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of Fixed-Dose Four-Factor Prothrombin Complex Concentrate for Emergent Warfarin Reversal in Patients with Intracranial Hemorrhage. Scott R; Kersten B; Basior J; Nadler M J Emerg Med; 2018 Jun; 54(6):861-866. PubMed ID: 29510892 [TBL] [Abstract][Full Text] [Related]
13. Effect of prothrombin complex concentrate on INR and blood coagulation system in emergency patients treated with warfarin overdose. Yasaka M; Oomura M; Ikeno K; Naritomi H; Minematsu K Ann Hematol; 2003 Feb; 82(2):121-3. PubMed ID: 12601493 [TBL] [Abstract][Full Text] [Related]
14. Rapid Warfarin reversal in the setting of intracranial hemorrhage: a comparison of plasma, recombinant activated factor VII, and prothrombin complex concentrate. Woo CH; Patel N; Conell C; Rao VA; Faigeles BS; Patel MC; Pombra J; Akins PT; Axelrod YK; Ge IY; Sheridan WF; Flint AC World Neurosurg; 2014 Jan; 81(1):110-5. PubMed ID: 23220122 [TBL] [Abstract][Full Text] [Related]
15. Individualized dosing regimen for prothrombin complex concentrate more effective than standard treatment in the reversal of oral anticoagulant therapy: an open, prospective randomized controlled trial. van Aart L; Eijkhout HW; Kamphuis JS; Dam M; Schattenkerk ME; Schouten TJ; Ploeger B; Strengers PF Thromb Res; 2006; 118(3):313-20. PubMed ID: 16182346 [TBL] [Abstract][Full Text] [Related]
16. Optimizing the dose of three-factor prothrombin complex concentrate in traumatic brain injury patients on warfarin therapy. Huynh TK; Costello JL; Rebuck JA Pharmacotherapy; 2014 Mar; 34(3):260-4. PubMed ID: 24338807 [TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of four-factor prothrombin complex concentrate fixed, weight-based dosing for reversal of warfarin anticoagulation. Endres K; St Bernard R; Chin-Yee I; Hsia C; Lazo-Langner A Hematology; 2020 Dec; 25(1):489-493. PubMed ID: 33317427 [TBL] [Abstract][Full Text] [Related]
18. Dosing of 3-factor prothrombin complex concentrate for international normalized ratio reversal. Baggs JH; Patanwala AE; Williams EM; Erstad BL Ann Pharmacother; 2012 Jan; 46(1):51-6. PubMed ID: 22190253 [TBL] [Abstract][Full Text] [Related]
19. The clinical significance of differences between point-of-care and laboratory INR methods in over-anticoagulated patients. Lawrie AS; Hills J; Longair I; Green L; Gardiner C; Machin SJ; Cohen H Thromb Res; 2012 Jul; 130(1):110-4. PubMed ID: 21937093 [TBL] [Abstract][Full Text] [Related]
20. Prothrombin complex concentrate for the urgent reversal of warfarin. Assessment of a standard dosing protocol. Wozniak M; Kruit A; Padmore R; Giulivi A; Bormanis J Transfus Apher Sci; 2012 Jun; 46(3):309-14. PubMed ID: 22503307 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]